RecruitingNot Applicable

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

Turkey (Türkiye)60 participantsStarted 2026-03-02

Plain-language summary

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women aged ≥18 years * Planned total abdominal hysterectomy for benign indications * Sexually active within the last 4 weeks * Able to complete the Female Sexual Function Index (FSFI) questionnaire * Provided written informed consent Exclusion Criteria: * Gynecologic malignancy * Major additional pelvic reconstructive surgery * Severe psychiatric or neurologic disorder * Inability to complete follow-up assessments

What they're measuring

3-Month Postoperative Female Sexual Function Index Total Score

Timeframe: Assessed at postoperative month 3 (±2 weeks)

Trial details

NCT IDNCT07431788

SponsorErkan Gol

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2027-02

Contact for this trial

Erkan Göl, MD

+905398517917 drerkangol@gmail.com

View on ClinicalTrials.gov More Leiomyoma (Uterine Fibroids) trials